Apogee Therapeutics, Inc. Operating Lease Right-of-Use Assets
Apogee Therapeutics, Inc. (APGE) had Operating Lease Right-of-Use Assets of $6.71 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-08-10
- 2026-06-30: Operating Lease, Right-of-Use Asset $6.71M.
- 2026-03-31: Operating Lease, Right-of-Use Asset $7.71M.
- 2025-12-31: Operating Lease, Right-of-Use Asset $8.69M.
- 2025-09-30: Operating Lease, Right-of-Use Asset $9.65M.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2026-06-30 | $6.71M 10-Q · filed 2026-08-10 |
| 2026-03-31 | $7.71M 10-Q · filed 2026-05-11 |
| 2025-12-31 | $8.69M 10-Q · filed 2026-08-10 |
| 2025-09-30 | $9.65M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $10.59M 10-Q · filed 2025-08-11 |
| 2025-03-31 | $11.51M 10-Q · filed 2025-05-12 |
| 2024-12-31 | $11.37M 10-K · filed 2026-03-02 |
| 2024-09-30 | $12.13M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $4.23M 10-Q · filed 2024-08-12 |
| 2024-03-31 | $1.95M 10-Q · filed 2024-05-13 |
| 2023-12-31 | $2.22M 10-K · filed 2025-03-03 |